Surgical Information Systems (SIS) Earns Tenth Consecutive #1 Client Rating in Ambulatory Surgical Center IT User Satisfaction, Black Book Survey

January 7, 2025 9:00 AM

Client experience survey results from 1,914 physicians, clinicians, and administrative staff rate Surgical Information Systems (SIS) first among Ambulatory Surgical Center (ASC) technology vendors for a tenth consecutive year. Surgical Information Systems achieved top ratings in 12 of the 18 key performance indicators focused on vendors delivering outpatient perioperative software solutions.Black Book Research announced the highest user...

Read more

Quantum Biopharma Ltd. Approved to Dual List on Upstream

January 7, 2025 8:30 AM

Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma" or the "Company"), today announced its approval to dual list its shares on Upstream, a MERJ Exchange market and global securities trading app. Trading becomes available on Upstream Tuesday, January 14, 2025, at 10:00am ET under the ticker symbol ‘QNTM.'The dual listing on Upstream is designed to provide Quantum the opportunity to access a global investor base outside...

Read more

Theralogix Launches TheraCran Max: Dual-Action Defense for Urinary Tract Health

January 7, 2025 8:00 AM

Theralogix, a trusted leader in the nutritional supplement industry, proudly announces the launch of TheraCran® Max, a premium dual-action supplement designed to deliver daily urinary tract health support.* By combining content-certified cranberry extract with pure d-mannose, TheraCran Max provides a comprehensive, broad-spectrum approach to urinary health.*TheraCran Max utilizes two scientifically backed ingredients that work in complementary...

Read more

Septoplasty or Rhinoplasty? New Jersey Facial Plastic Surgeon Breaks Down the Difference

January 7, 2025 8:00 AM

In an effort to help people better understand their options for improving nasal function and facial aesthetics, Dr. Anni Wong, a leading otolaryngologist and facial plastic surgeon serving New Jersey, provides new expert insight on the differences between septoplasty and rhinoplasty. By clarifying the distinctions between these two procedures, Dr. Wong aims to empower patients with the knowledge they need to make informed decisions about their...

Read more

CBD Life Sciences, Inc. (CBDL) Secures Breakthrough Walmart Marketplace Approval for Mushroom Supplement, Setting the Stage for Unprecedented Growth

January 7, 2025 8:00 AM

CBD Life Sciences, Inc. (OTC PINK:CBDL), a leader in wellness innovation, is thrilled to announce that its Mushroom Madness Rise Gummies, featuring a powerful Lion's Mane mushroom blend, have officially been approved for sale and are now available on Walmart Marketplace. This monumental approval opens the door for CBDL to tap into Walmart's expansive e-commerce ecosystem, providing a pathway to substantial revenue growth while strengthening its...

Read more

Telomir Pharmaceuticals Confirms Lifespan Restoration and Normalization of Accelerated Aging in Preclinical Model of Progeria (A Rare Genetic Disorder Causing Rapid Aging)

January 7, 2025 8:00 AM

MIAMI, FL / ACCESSWIRE / January 7, 2025 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) ("Telomir"), an emerging leader in age-reversal science focused on treating the root causes of diseases rather than just their symptoms, announced today potentially groundbreaking findings from a preclinical progeria lifespan study conducted in collaboration with Nagi Bioscience SA. Utilizing C. elegans (nematode) models, in which the study demonstrated...

Read more

Phlebotomy Equipments Market: Global Industry Analysis and Opportunity Assessment 2025 to 2035 | Future Market Insights, Inc.

January 7, 2025 6:30 AM

The global phlebotomy equipment market is poised for substantial growth, with sales projected to increase from USD 14,693.1 million in 2025 to USD 21,468.1 million by 2035, reflecting a steady CAGR of 3.9% over the forecast period. In 2024, the market generated a revenue of USD 14,044.3 million, underlining its upward trajectory. Major factors driving the adoption of phlebotomy equipment are:• The rising frequency of infectious illnesses, an...

Read more

Zomedica Announces License & Supply Agreement with Cresilon Inc. to Market and Sell Vetigel(R) Hemostatic Gel in the Animal Health Market

January 7, 2025 6:30 AM

ANN ARBOR, MI / ACCESSWIRE / January 7, 2025 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for equine and companion animals, today announced that it had entered into a license and supply agreement with Cresilon, Inc. to market and sell the Vetigel® hemostatic gel product line on an exclusive basis in the United States and on a...

Read more

Senzime Secures Multiple New Hospital Contracts for its Next-Generation TetraGraph System

January 7, 2025 5:50 AM

UPPSALA, SE / ACCESSWIRE / January 7, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) Senzime,an industry leader in precision-based patient monitoring solutions, today announced multiple hospital contract wins for its new TetraGraph system, and that first customer deliveries of the system has commenced as planned.The next-generation TetraGraph system was launched at the ANESTHESIOLOGY congress in US in late October 2024. Following the launch, the new...

Read more

CORRECTION: 2025's Top-Rated EHR Vendors Across 40 Medical & Surgical Specialties: Black Book Insights Into Innovation and Client-Centric Excellence

January 7, 2025 5:30 AM

Black Book, a leader in healthcare industry insights, has released its 2025 list of the top-rated Electronic Health Records (EHR) vendors for medical and surgical ambulatory care physicians. This prestigious list, based on a comprehensive nine month survey of 33,516 respondents across the U.S., recognizes the leading companies within various medical specialties for their innovative solutions, exceptional performance, and user satisfaction. The...

Read more

Shanghai Korain Biotech Leverages Bioz Badges to Boost Sales and Highlight Product Credibility

January 7, 2025 4:00 AM

Bioz, Inc., a leader in AI-driven product engagement and citation analytics, is proud to announce the successful integration of Bioz Badges onto the website of Bioassay Technology Laboratory (BT Lab), hosted by Shanghai Korain Biotech. This collaboration has already shown significant impact, boosting the visibility of Korain Biotech's offerings, enhancing customer engagement, and driving a notable increase in sales conversion.By leveraging Bioz...

Read more

Prefilled Formalin Vials Market Strong Growth USD 661.8 Million by 2035 at a 3.8% CAGR, Driven by Rising Healthcare Needs | Future Market Insights, Inc.

January 7, 2025 2:50 AM

The global Prefilled Formalin Vials Market is poised for steady growth between 2025 and 2035, with a projected market size of USD 459.3 million in 2025 and expected to expand to USD 661.8 million by 2035. This represents a compound annual growth rate (CAGR) of 3.8% over the forecast period. Formalin vials, which are prefilled with formalin solution used primarily in the preservation of biological specimens, play a crucial role in laboratory...

Read more

Kuros Biosciences USA, Inc. Announces an Exclusive Strategic Agreement with the Medtronic Spinal Division

January 7, 2025 1:20 AM

Kuros Biosciences USA Inc., ("Kuros"), a wholly owned subsidiary of Kuros Biosciences AG, a global leader in advanced musculoskeletal bone healing technologies, today announced a strategic five-year, exclusive sales agency agreement with Medtronic, a leading global healthcare technology company. The agreement provides Medtronic with exclusivity in certain spine geographies within the U.S. market, underscoring a shared commitment to expanding...

Read more

Protagonist Therapeutics Reports Granting of Inducement Awards

January 6, 2025 4:05 PM

Protagonist Therapeutics, Inc. (Nasdaq:PTGX) today reported that on January 2, 2025, it issued inducement awards to Newman Yeilding, M.D., upon his appointment to the role of Executive Vice President, Chief Scientific Officer, in accordance with the terms of his employment offer letter. Dr. Yeilding served in a consultant role as the Company's Chief Scientific Advisor from August 1, 2024 through January 1, 2025. The awards were granted under the...

Read more

As 2025 Begins, Healthcare Costs Remain a Concern for Small Businesses and Families

January 6, 2025 2:45 PM

With the new year underway, many individuals, families, and small businesses are evaluating their health insurance plans amid ongoing concerns about affordability and transparency in the healthcare system. Rising premiums and unexpected medical bills continue to create financial strain, prompting a search for alternatives that offer predictable costs and comprehensive benefits.Challenges in the Healthcare LandscapeMedical billing errors remain a...

Read more

Why Diversity in Clinical Trials Is So Important

January 6, 2025 10:45 AM

NORTHAMPTON, MA / ACCESSWIRE / January 6, 2025 / Clinical trials are essential for the development of health care products, and it is increasingly recognized that there is a need for more diversity in trial participation. With new draft Food and Drug Administration (FDA) guidelines in the US to make Diversity Action Plans mandatory, we showcase Teva's work in this space and highlight its importance in drug development.Did you know that:Local...

Read more

Frontage Announces Co-CEO Promotions

January 6, 2025 9:00 AM

Frontage Holdings Corporation today announced that Dr. Abdul Mutlib has decided to step aside from his current role as CEO of the company to facilitate the Company's leadership succession planning and that Chief Strategy Officer Dr. Wentao Zhang and President Dr. John Lin have been promoted to Co-CEOs of the company effective today. Going forward, Dr. Mutlib will assume an advisory role as the Chief Scientific and Strategy Officer, ensuring...

Read more

Frontage Announces Co-CEO Promotions

January 6, 2025 9:00 AM

Frontage Holdings Corporation today announced that Dr. Abdul Mutlib has decided to step aside from his current role as CEO of the company to facilitate the Company's leadership succession planning and that Chief Strategy Officer Dr. Wentao Zhang and President Dr. John Lin have been promoted to Co-CEOs of the company effective today. Going forward, Dr. Mutlib will assume an advisory role as the Chief Scientific and Strategy Officer, ensuring...

Read more

Aytu BioPharma to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025

January 6, 2025 9:00 AM

DENVER, CO / ACCESSWIRE / January 6, 2025 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on commercializing novel therapeutics, today announced that CEO, Josh Disbrow, will participate in a webcasted fireside chat at the Lytham Partners 2025 Investor Healthcare Summit, taking place virtually on Monday, January 13, 2025.The fireside chat will take place at 10:00 a.m. Eastern Time on Monday,...

Read more

CASI Announces First Patient Dosed in Phase 1/2 Clinical Trial of CID-103 in Immune Thrombocytopenia

January 6, 2025 8:00 AM

BEIJING, CHINA / ACCESSWIRE / January 6, 2025 / CASI Pharmaceuticals, Inc. (Nasdaq:CASI), a biopharmaceutical company specializing in the development and commercialization of innovative therapeutic and pharmaceutical products announced that the first patient has been dosed in the Phase 1/2 trial to evaluate the safety and tolerability of CID-103 in adult patients with chronic Immune Thrombocytopenia (ITP) in China."Dosing the first patient in...

Read more